Apyx Medical Corporation APYX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 49.97% | 54.24% | 52.22% | 48.88% | 39.16% |
| Total Depreciation and Amortization | 40.83% | 23.97% | 9.35% | -5.42% | -14.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.44% | -26.22% | -31.61% | -47.49% | -45.64% |
| Change in Net Operating Assets | -400.22% | -304.15% | -27.79% | -44.86% | -75.17% |
| Cash from Operations | -8.76% | 36.57% | 55.67% | 51.46% | -1.37% |
| Capital Expenditure | -28.13% | -50.81% | -54.29% | -90.18% | -21.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -28.13% | -50.81% | -54.29% | -90.18% | -21.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 99.83% | 99.82% |
| Issuance of Common Stock | 41.09% | 41.09% | 39.83% | -- | 23,233.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -41.71% | -6.34% | 20.00% | -125.22% | -120.81% |
| Cash from Financing | 41.19% | 42.26% | 42.03% | -71.23% | -71.64% |
| Foreign Exchange rate Adjustments | -60.53% | -601.92% | -512.39% | -315.52% | -590.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 50.13% | 102.01% | 99.99% | -148.95% | -123.78% |